Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
10/2010
10/27/2010EP1907399B1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
10/27/2010EP1838715B1 Method for the preparation of maytansinoid esters
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010CN1829722B Regioselective synthesis of CCI-779
10/27/2010CN101027309B Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
10/26/2010USRE41895 Epothilone derivatives
10/26/2010USRE41893 Epothilone derivatives
10/26/2010US7820838 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
10/26/2010US7820823 Dual action antibiotics
10/26/2010US7820812 Methods of manufacturing crystalline forms of rapamycin analogs
10/26/2010US7820702 Sulfonylpyrrolidine modulators of androgen receptor function and method
10/26/2010US7820664 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/26/2010US7820655 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
10/26/2010CA2418921C Novel composition
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010120998A1 Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
10/21/2010WO2010084499A3 Bicyclic heterocyclic spiro compounds
10/21/2010WO2009110007A8 Spiro derivatives of parthenin as novel anticancer agents
10/21/2010WO2009020470A3 Cgrp receptor antagonists
10/21/2010US20100268329 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
10/21/2010US20100267964 N-heterocyclylphenyl-substituted cyclic ketoenols
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267685 Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010CA2755554A1 Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
10/20/2010EP2240495A1 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
10/20/2010EP2240485A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
10/20/2010EP2240467A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
10/20/2010EP2240454A1 Mesoionic pesticides
10/20/2010EP2240016A1 Ampk modulators
10/20/2010EP2049491B1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/20/2010EP1789377B1 Alternative synthesis of renin inhibitors and intermediates thereof
10/20/2010EP1732929B1 Tricyclic benzopyran compound as anti-arrhythmic agents
10/20/2010CN101863909A Norcantharidin derivative and activity testing method and application thereof
10/20/2010CN101863904A Preparation method of high-purity Levofloxacin semihydrate
10/20/2010CN101863886A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/19/2010US7816524 Methods of preparing quinolone analogs
10/19/2010CA2400614C Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/19/2010CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis
10/14/2010WO2010117077A1 Therapeutic agent for chorioretinal diseases comprising sirolimus derivative as active ingredient
10/14/2010WO2010116270A1 Ep2/4 agonists
10/14/2010US20100261719 Chemical compounds
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010CA2758072A1 Macrocyclic serine protease inhibitors
10/13/2010EP2239565A1 Optical-isomer separating agent for chromatography and process for producing the same
10/13/2010EP2239258A2 Tetrahydrobenzoxazine
10/13/2010EP2238144A1 Compounds comprising a cyclobutoxy group
10/13/2010EP2238138A1 Tricyclic nitrogen compounds and their use as antibacterial agents
10/13/2010EP2004658B1 Condensed imidazole derivatives as aromatase inhibitors
10/13/2010EP1783129B1 Spiropiperidyl rifamycins for the treatment of microbacterial infections
10/13/2010EP1480644B1 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
10/13/2010EP1204642B1 Fungicides
10/13/2010CN101861309A SALARIN and TULEARIN, compositions and uses thereof
10/13/2010CN101084217B Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
10/12/2010US7812167 Substituted (thiazol-2-yl)-amides or sulfonamides as glucokinase activators useful in the treatment of type 2 diabetes
10/12/2010US7812155 reacting rapamycin with an alkyl triflate, purifying the resulting reaction product with a normal phase chromatograph and further purifying with a reverse phase chromatography
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812032 crystalline forms of zotarolimus (ABT-578); bioavailability, solubility
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7812013 4-Imino-2-methyl-3,5,13-triazatetracyclo[15.3.1.1(2,5).1(7,11)]tricosa-1(21),7,9,11(22),17,19-hexaene-12,23-dione, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases
10/07/2010WO2010114971A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
10/07/2010WO2010114958A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
10/07/2010WO2010112865A1 5-ht receptor modulating compounds
10/07/2010US20100256388 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
10/07/2010US20100256361 Thiazole derivatives
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256129 Selective androgen receptor modulators (sarms) and uses thereof
10/07/2010US20100256128 Gamma secretase modulators
10/07/2010US20100256124 Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100251490 Reactive dyes, processes for their preparation and their use
10/07/2010CA2757106A1 5-ht receptor modulating compounds
10/07/2010CA2756989A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
10/06/2010EP2235007A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
10/06/2010EP2234999A1 Heteroaryl derivatives as orexin receptor antagonists
10/06/2010EP1781672B1 Solvent free amorphous rapamycin
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010CN1914212B Polymorphic forms of a GABAA agonist
10/06/2010CN101855229A Spirocyclic aminoquinolones as GSK-3 inhibitors
10/06/2010CN101855228A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
10/06/2010CN101855224A Equilibrative nucleoside transporter ENT1 inhibitors
10/06/2010CN101851648A Method for preparing demethyl rapamycin by utilizing bacillus megaterium
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807833 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
10/05/2010US7807418 Method for producing hybrid polyketide synthases
10/05/2010US7807191 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/05/2010US7807075 Photochromic compositions and light transmissible articles
10/05/2010CA2322516C Sustained release macrolide compositions
09/2010
09/30/2010WO2010110380A1 Fused piperidine compound and pharmaceutical agent comprising same
09/30/2010WO2010109299A2 Substituted 1, 4-dioxa-8-azaspiro [4,5] decanes useful as fungicides and a process for the preparation thereof
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249403 Use of oxazine compounds for making chromogenic materials
09/30/2010US20100249201 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249132 Imidazole derivatives
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010US20100247519 Heterocyclic aspartyl protease inhibitors
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 220